SGLT1 Inhibition Attenuates Apoptosis in Diabetic Cardiomyopathy via the JNK and p38 Pathway

Background: Recent studies have revealed that a novel selective sodium-glucose cotransporter 1 (SGLT1) inhibiton has shown beneficial effects in cardiovascular diseases. However, the question of whether SGLT1 inhibition influences diabetic cardiomyopathy (DCM) remains unanswered. In this study, we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Na, Lin, Hui, Yang, Qi, Lu, Wenqiang, Sun, Zhenzhu, Sun, Shimin, Meng, Liping, Chi, Jufang, Guo, Hangyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883645/
https://www.ncbi.nlm.nih.gov/pubmed/33597877
http://dx.doi.org/10.3389/fphar.2020.598353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883645/
https://www.ncbi.nlm.nih.gov/pubmed/33597877
http://dx.doi.org/10.3389/fphar.2020.598353

Ejemplares similares